NoBlaBlaFinance

Filings Companies Sectors Calendar

Log in Français

Archive

Filings in February 2026

1,744 filings

← January 2026 March 2026 →

10/02/2026
Déclaration du nombre total de droits de vote et d’actions composant le capital social de 74Software au 31 janvier 2026
74SOFTWAREVoting rights and capitalFrench
10/02/2026
Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Linedata ServicesVoting rights and capitalFrench
10/02/2026
Déclaration des droits de vote au 31 janvier 2026
BoironVoting rights and capitalFrench
10/02/2026
Franchissement de seuils
NexansThreshold crossingFrench
10/02/2026
Franchissement de seuil
ViridienThreshold crossingFrench
10/02/2026
Franchissement de seuils
RexelThreshold crossingFrench
10/02/2026
Franchissement de seuil
Ubisoft EntertainmentThreshold crossingFrench
10/02/2026
Franchissement de seuil
ViridienThreshold crossingFrench
10/02/2026
Franchissement de seuils
DBV TechnologiesThreshold crossingFrench
10/02/2026
Quadient Digital Accelerates with Landmark Wins and Double-Digit Bookings Growth in Q4
Quadient S.A.Inside informationFR
10/02/2026
SHOWROOMPRIVÉ ANNOUNCES ITS 2026 FINANCIAL CALENDAR
SRP GroupeInside informationFR
10/02/2026
STMicroelectronics présente le premier microcontrôleur automobile avec un accélérateur d’IA pour l’intelligence embarquée
Stmicroelectronics NVInside informationFrench
10/02/2026
Inside Information / Other news releases
VituraInside informationFR
10/02/2026
Elis: Disclosure of trading in own shares occured from February 2 to February 6, 2026
ElisShare buybackFR
10/02/2026
Inside Information / Other news releases
Gensight Biologics S.A.Inside informationFR
10/02/2026
VIEL ET COMPAGNIE : Chiffre d’affaires de 1 266,9 millions d’euros sur l’année 2025 en croissance de 7,4% à cours de change courants -Croissance de 10,7% du chiffre d’affaires à cours de change constants
Viel et CompagnieInside informationFrench
10/02/2026
Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026
Nicox SAInside informationFR
10/02/2026
Waga Energy posts a +23% yoy RNG production revenue growth
Waga EnergyInside informationFR
10/02/2026
Kering - 2025 results: Sequential improvement, unlocking the next phase of sustainable & profitable growth
KeringInside informationFR
09/02/2026
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
DBV TechnologiesInside informationFR
09/02/2026
VINCI: Publication of audited consolidated financial statements at 31 December 2025
VinciInside information
09/02/2026
VINCI : Publication des comptes consolidés certifiés au 31 décembre 2025
VinciEarnings releaseFrench
09/02/2026
Inside Information / Other news releases
MercialysInside informationFR
09/02/2026
Casino Group Communication
Casino Guichard-PerrachonInside informationFR
09/02/2026
PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 02 FEVRIER 2026 au 06 FEVRIER 2026
Patrimoine et CommerceShare buybackFrench
09/02/2026
Successful €8m rights issue
AudaciaInside informationFR
09/02/2026
Amundi : Programme de rachat d’actions - Déclaration des transactions sur actions propres réalisées du 4 au 6 février 2026
AmundiShare buybackFrench
09/02/2026
Sanofi: Disclosure of trading in own shares
SanofiShare buybackFR
09/02/2026
Ipsen - January 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
Ipsen SAVoting rights and capitalFR
09/02/2026
CRCAM Alpes Provence : déclarations_Hebdomadaires_CAAP_S6-2026
Caisse Regionale de Credit Agricole Mutuel Alpes ProvenceShare buybackFrench
09/02/2026
Danone: Information on the total number of voting rights and shares
DanoneVoting rights and capitalFR
09/02/2026
Caisse Française de Financement Local: EMTN 2022-2 B
Natixis Corporate and Investment Banking LuxembourgInside informationFR
09/02/2026
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors
AB ScienceInside informationFR
09/02/2026
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
EmeisVoting rights and capitalFrench
09/02/2026
VALLOUREC : DISCLOSURE OF TRADING IN OWN SHARES FROM 02/02/2026 TO 02/06/2026
VallourecShare buybackFR
09/02/2026
Project to transfer Plastivaloire Group shares to the Euronext Growth market
Plastiques du Val de LoireInside informationFR
09/02/2026
Acquisition ou cession des actions de l'émetteur / Modalités de mise à disposition du descriptif du programme de rachat
EmeisShare buybackFrench
09/02/2026
RUBIS: Transactions carried out within the framework of the share buyback programme (excluding transactions within the liquidity agreement) – 2 to 6 February 2026
RubisShare buybackFR
09/02/2026
Déclaration des transactions sur actions propres
Societe Centrale des Bois et Scieries de la MancheShare buybackFrench
09/02/2026
DISCLOSURE FISCAL 2026/14 OF TRANSACTIONS ON TREASURY SHARES
Pluxee N.V.Inside informationFR
09/02/2026
LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Lanson-BCCVoting rights and capitalFrench
09/02/2026
Aramis Group - Declaration of transactions on own shares conducted from February 2 to February 6, 2026
Aramis GroupShare buybackFR
09/02/2026
Declaration of voting rights at the end of January 2026
Opmobility SEVoting rights and capitalFR
09/02/2026
Information relative au nombre total de droits de vote et d'actions composant le capital au 31 janvier 2026
Diagnostic Medical SystemsVoting rights and capitalFrench
09/02/2026
Lumibird was selected by Rheinmetall for the Skyranger 30 air defence system
LumibirdInside informationFR
09/02/2026
Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version)
Eurofins Scientific SEShare buyback
09/02/2026
Touax: share capital and voting rights at 31012026
Touax SCAVoting rights and capitalFR
09/02/2026
Periodic disclosure on the buyback program
Racing Force S.P.A.Share buyback
09/02/2026
Un chiffre d'affaires de 400,3 M EUR en 2025, conforme aux attentes du Groupe
DelfingenInside informationFrench
09/02/2026
INFORMATION RELATIVE AUX OPÉRATIONS EFFECTUÉES DANS LE CADRE DU PROGRAMME DE RACHAT D'ACTIONS DU 3 AU 6 FÉVRIER 2026
Groupe LDLCShare buybackFrench
09/02/2026
Revenue of EUR 400.3m in 2025, in line with the Group's expectations
DelfingenEarnings releaseFrench
09/02/2026
DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
DamartexVoting rights and capitalFrench
09/02/2026
260209 BENETEAU CA annuel 2025
BeneteauInside informationFrench
09/02/2026
260209 BENETEAU FY 2025 Revenue
BeneteauEarnings release
09/02/2026
Disclosure of the number of shares and the total number of voting rights as of January 31, 2026
EurazeoVoting rights and capitalFR
09/02/2026
FORVIA: Total number of voting rights and shares forming the share capital
ForviaVoting rights and capitalFR
09/02/2026
Sogeclair: Voting rights as at 2026/01/31
SogeclairVoting rights and capitalFR
09/02/2026
Disclosure of transactions in own shares from February 2 to February 6, 2026
EurazeoShare buybackFR
09/02/2026
Changes in the composition of the Intrasense Board of Directors
IntrasenseInside informationFR
09/02/2026
HIGHCO : SHAREHOLDING
HighcoInside informationFR
09/02/2026
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of January 31, 2026
Dassault SystemesVoting rights and capitalFR
09/02/2026
Directorate change
Segro Public Limited CompanyInside information
09/02/2026
ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
AltareaVoting rights and capitalFrench
09/02/2026
Déclaration des droits de vote au 31 janvier 2026
Prismaflex InternationalVoting rights and capitalFrench
09/02/2026
Disclosure of total number of voting rights and number of shares in the capital at January 31, 2026
L'OrealInside informationFR
09/02/2026
Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
CNP AssurancesInside information
09/02/2026
Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
Aeroports de ParisInside information